Blood products: a significant risk factor for long-term catheter-related bloodstream infections in cancer patients.
Data obtained from a previous prospective randomized study in cancer patients conducted at our institution were analyzed to investigate risk factors for catheter-related (CR) bloodstream infections (BSIs). Our recent analysis showed that the administration of blood products through central venous catheters was a risk factor for CR BSI, whereas thrombocytopenia during catheterization may have provided protection against CR BSI, as did central venous catheter insertion under maximal sterile barrier precautions
Hanna
H A
HA
University of Texas M.D. Anderson Cancer Center, Section of Infection Control, Houston 77030, USA.
Raad
I
I
D000293:Adolescent; D000328:Adult; D000368:Aged; D016913:Blood Component Transfusion; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D003428:Cross Infection / Q000209:etiology*; D004866:Equipment Contamination; D006801:Humans; D016015:Logistic Models; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors